Consensus West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Real-time Estimate Cboe BZX Other stock markets 12:12:17 2024-05-09 pm EDT			5-day change	1st Jan Change
359 ^USD	-2.10%		-2.46%	+2.07%

Apr. 26	Declaration of Voting Results of the West Pharmaceutical Services Inc	CI
Apr. 26	Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc	CI

Evolution of the average Target Price on West Pharmaceutical Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

94c1c91687497c22095f96.NVCzeB3J72lKL9FZDVYt8teVc-1mVWiNStHrTEV9bMs.b2HkFkSWhyUvRbUfSGNGpJbSXodUJVC_DKiGOwg7W4lmJ-UtSp6jLSAZmA~184b96accc3afbda6c0f6a2ecfd68ea7

Analyst Recommendations on West Pharmaceutical Services, Inc.

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	Apr. 26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	Apr. 26	MT
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	Apr. 25	MT
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	Feb. 16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	Feb. 16	MT
Forget about rate cuts...	Feb. 16
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
Wall Street ends higher as retail sales slump feeds hopes for rate cuts	Feb. 15	RE
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	Feb. 13	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Joe Biden and Xi Jinping almost made up	Nov. 16
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	Nov. 16
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	23-10-27	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	23-10-27	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	23-08-30	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	23-08-21	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	23-07-20	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	23-07-17	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	23-07-10	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	23-06-16	MT
UBS Adjusts West Pharmaceutical Services Price Target to $365 From $356, Maintains Neutral Rating	23-04-28	MT
Stephens Upgrades West Pharmaceutical Services to Overweight From Equalweight, Raises Price Target to $400 From $330	23-04-11	MT
UBS Raises Price Target on West Pharmaceutical Services to $356 From $324, Keeps Neutral Rating	23-04-10	MT